EE9600202A - Toimeaine pärsitud vabanemisega karbamasepiini ravimvorm - Google Patents

Toimeaine pärsitud vabanemisega karbamasepiini ravimvorm

Info

Publication number
EE9600202A
EE9600202A EE9600202A EE9600202A EE9600202A EE 9600202 A EE9600202 A EE 9600202A EE 9600202 A EE9600202 A EE 9600202A EE 9600202 A EE9600202 A EE 9600202A EE 9600202 A EE9600202 A EE 9600202A
Authority
EE
Estonia
Prior art keywords
carbamazepine
pct
sustained release
sec
release formulation
Prior art date
Application number
EE9600202A
Other languages
English (en)
Other versions
EE03954B1 (et
Inventor
Landgraf Karl-Friedrich
Reiss Sabine
Schubert Eberhard
Original Assignee
Arzneimittelwerk Dresden Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arzneimittelwerk Dresden Gmbh filed Critical Arzneimittelwerk Dresden Gmbh
Publication of EE9600202A publication Critical patent/EE9600202A/et
Publication of EE03954B1 publication Critical patent/EE03954B1/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
EE9600202A 1994-07-01 1995-06-22 Toimeaine pärsitud vabanemisega karbamasepiini ravimvormi valmistamise meetod EE03954B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19944423078 DE4423078B4 (de) 1994-07-01 1994-07-01 Verfahren zur Herstellung einer Carbamazepin-Arzneiform mit verzögerter Wirkstofffreisetzung
PCT/DE1995/000805 WO1996001112A1 (de) 1994-07-01 1995-06-22 Carbamazepin-arzneiform mit verzögerter wirkstofffreisetzung

Publications (2)

Publication Number Publication Date
EE9600202A true EE9600202A (et) 1997-06-16
EE03954B1 EE03954B1 (et) 2003-02-17

Family

ID=6522000

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9600202A EE03954B1 (et) 1994-07-01 1995-06-22 Toimeaine pärsitud vabanemisega karbamasepiini ravimvormi valmistamise meetod

Country Status (23)

Country Link
US (1) US5888545A (et)
EP (1) EP0768882B1 (et)
JP (1) JPH10502358A (et)
KR (1) KR100344477B1 (et)
CN (1) CN1101191C (et)
AT (1) ATE169818T1 (et)
BG (1) BG62794B1 (et)
BR (1) BR9508202A (et)
CA (1) CA2194216A1 (et)
CZ (1) CZ288028B6 (et)
DE (2) DE4423078B4 (et)
DK (1) DK0768882T3 (et)
EE (1) EE03954B1 (et)
ES (1) ES2122630T3 (et)
GE (1) GEP19991819B (et)
HU (1) HU221486B (et)
LT (1) LT4251B (et)
LV (1) LV11820B (et)
PL (1) PL180979B1 (et)
RU (1) RU2141825C1 (et)
SK (1) SK282303B6 (et)
UA (1) UA32598C2 (et)
WO (1) WO1996001112A1 (et)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6162466A (en) * 1999-04-15 2000-12-19 Taro Pharmaceutical Industries Ltd. Sustained release formulation of carbamazepine
BRPI0610257A2 (pt) * 2005-04-25 2010-06-08 Teva Pharma formulações de liberação prolongada
US8795723B2 (en) * 2005-09-09 2014-08-05 Angelini Pharma Inc. Sustained drug release compositions
US20070160960A1 (en) * 2005-10-21 2007-07-12 Laser Shot, Inc. System and method for calculating a projectile impact coordinates
FR2940910A1 (fr) * 2009-01-09 2010-07-16 Vetoquinol Sa Nouveau comprime a base de s-adenosyl-methionine
CN105997916A (zh) * 2016-07-19 2016-10-12 南京正宽医药科技有限公司 一种卡马西平片及其制备方法
CN108125922A (zh) * 2018-01-14 2018-06-08 上海安必生制药技术有限公司 一种卡马西平口服缓释制剂及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK150008C (da) * 1981-11-20 1987-05-25 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
SE8203953D0 (sv) * 1982-06-24 1982-06-24 Astra Laekemedel Ab Pharmaceutical mixture
DK151608C (da) * 1982-08-13 1988-06-20 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat med kontrolleret afgivelse
CH668187A5 (de) * 1986-08-07 1988-12-15 Ciba Geigy Ag Therapeutisches system mit systemischer wirkung.
IL86211A (en) * 1987-05-04 1992-03-29 Ciba Geigy Ag Oral forms of administration for carbamazepine in the forms of stable aqueous suspension with delayed release and their preparation
US5326572A (en) * 1989-03-23 1994-07-05 Fmc Corporation Freeze-dried polymer dispersions and the use thereof in preparing sustained-release pharmaceutical compositions

Also Published As

Publication number Publication date
EE03954B1 (et) 2003-02-17
EP0768882B1 (de) 1998-08-19
ES2122630T3 (es) 1998-12-16
WO1996001112A1 (de) 1996-01-18
BG62794B1 (bg) 2000-08-31
CA2194216A1 (en) 1996-01-18
LT97012A (en) 1997-08-25
CN1101191C (zh) 2003-02-12
UA32598C2 (uk) 2001-02-15
US5888545A (en) 1999-03-30
LV11820B (en) 1997-12-20
CZ288028B6 (cs) 2001-04-11
BG101080A (en) 1997-08-29
JPH10502358A (ja) 1998-03-03
DE4423078A1 (de) 1996-01-04
RU2141825C1 (ru) 1999-11-27
DE4423078B4 (de) 2005-01-13
HUT76821A (en) 1997-11-28
ATE169818T1 (de) 1998-09-15
CZ382696A3 (en) 1997-05-14
BR9508202A (pt) 1997-11-11
HU221486B (en) 2002-10-28
DE59503283D1 (de) 1998-09-24
EP0768882A1 (de) 1997-04-23
PL317996A1 (en) 1997-05-12
DK0768882T3 (da) 1999-05-25
KR100344477B1 (ko) 2002-11-23
SK282303B6 (sk) 2002-01-07
GEP19991819B (en) 1999-11-05
HU9603565D0 (en) 1997-02-28
SK164696A3 (en) 1997-06-04
LV11820A (lv) 1997-08-20
CN1153475A (zh) 1997-07-02
LT4251B (en) 1997-12-29
KR970703774A (ko) 1997-08-09
PL180979B1 (pl) 2001-05-31

Similar Documents

Publication Publication Date Title
ATE198152T1 (de) Oral anzuwendende arzneizubereitung mit verzögerter wirkstoffabgabe
HUP9904174A2 (hu) Bőrön át történő adagoláshoz szánt gyógyszerkészítmények
ATE99927T1 (de) Pharmazeutische formulierungen.
HUP0203451A2 (hu) Új, tuberkolózis elleni gyógyszerkészítmények és eljárás előállításukra
CA2253980A1 (en) Locally administrable, biodegradable and sustained-release pharmaceutical composition for periodontitis and process for preparation thereof
BG100933A (en) Polymer coated tablets comprising amoxycilin and clavulanate
FR2752732B1 (fr) Forme galenique a liberation prolongee de milnacipran
EP0382077A3 (de) Diarylsubstituierte heterocyclische Verbindung, ihre Herstellung und Arzneimittel und Kosmetika daraus
DE69007623T2 (de) Arzneimittel mit verzögerter wirkstofffreigabe.
ES2051881T3 (es) Procedimiento de preparacion de un formulacion farmaceutica de liberacion prolongada.
BR9917012A (pt) Comprimido matricial, permitindo a liberação prolongada de gliclazida, após administração por via oral
ES2158101T3 (es) Formulaciones farmaceuticas efervescentes que contienen microcapsulas biodegradables de liberacion controlada.
RS50298B (sr) Direktno kompresibilna matrica za kontrolisano oslobađanje pojedinačnih dnevnih doza klaritromicina
ATE290854T1 (de) Carbamazepinformulierung mit verzögerter freigabe
EE9600202A (et) Toimeaine pärsitud vabanemisega karbamasepiini ravimvorm
BR0012775A (pt) Comprimido de microgrânulos com baixa dosagem de princìpio ativo contendo um diluente diretamente compressìvel, composição, e, processo de preparação do comprimido
SE9501671D0 (sv) Method and composition for prevention of posterior capsule opacification
DE69914472D1 (de) Levosimendanhaltige oral anzuwendende arzneimittel mit gesteuerter wirkstoffverabreichung
GR3024854T3 (en) Drugs for preventing the development of tolerance during treatment with benzodiazepine-receptor-binding substances.
ATE234096T1 (de) Pharmazeutische zusammensetzung zur systemischen transdermalen verabreichung mit dem wirkstoff morphin-6-glucuronid
DE69416034T2 (de) Pharmazeutische Zubereitung zur rektalen Verabreichung von pharmakologisch wirksamen Verbindungen
TH21515A (th) การปลดปล่อยซิซาไพรด์นาน

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20091231

KB4A Valid patent at the end of a year

Effective date: 20101231